Overview
2q31.1 microdeletion syndrome is a rare chromosomal disorder caused by a small deletion (microdeletion) on the long arm of chromosome 2 at band 31.1. This region contains several genes critical for limb and skeletal development, including the HOXD gene cluster. The syndrome is characterized by variable clinical features depending on the size and exact location of the deletion. Key features typically include limb anomalies (particularly affecting the hands and feet, such as brachydactyly, syndactyly, or split hand/foot malformation), intellectual disability of variable severity, growth retardation, and distinctive facial features. Facial dysmorphisms may include a prominent forehead, short nose, thin upper lip, and micrognathia. Some patients also present with congenital heart defects, genitourinary anomalies, and feeding difficulties in infancy. The severity of the condition varies considerably among affected individuals, largely depending on which genes are encompassed by the deletion. Deletions that include the HOXD gene cluster are more commonly associated with significant limb malformations, while deletions sparing this cluster may present with milder skeletal involvement but still feature developmental delay and intellectual disability. Additional clinical findings may include hypotonia, speech and language delay, and behavioral difficulties. There is currently no cure for 2q31.1 microdeletion syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific symptoms. This may include orthopedic interventions for limb anomalies, speech therapy, occupational therapy, special educational support, and cardiac or urological management as needed. Early intervention programs are recommended to optimize developmental outcomes. Genetic counseling is advised for affected families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 2q31.1 microdeletion syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 2q31.1 microdeletion syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 2q31.1 microdeletion syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 2q31.1 microdeletion syndrome.
Community
No community posts yet. Be the first to share your experience with 2q31.1 microdeletion syndrome.
Start the conversation →Latest news about 2q31.1 microdeletion syndrome
No recent news articles for 2q31.1 microdeletion syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 2q31.1 microdeletion syndrome
What is 2q31.1 microdeletion syndrome?
2q31.1 microdeletion syndrome is a rare chromosomal disorder caused by a small deletion (microdeletion) on the long arm of chromosome 2 at band 31.1. This region contains several genes critical for limb and skeletal development, including the HOXD gene cluster. The syndrome is characterized by variable clinical features depending on the size and exact location of the deletion. Key features typically include limb anomalies (particularly affecting the hands and feet, such as brachydactyly, syndactyly, or split hand/foot malformation), intellectual disability of variable severity, growth retardat
How is 2q31.1 microdeletion syndrome inherited?
2q31.1 microdeletion syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does 2q31.1 microdeletion syndrome typically begin?
Typical onset of 2q31.1 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.